In addition, analysis of SMARCA5 expression in gliomas with different WHO grades showed that, consistent with the TCGA data, SMARCA5 expression in high-grade gliomas was marked higher than in low-grade gliomas and normal tissue (Figure 6G). The gene discussed is SMARCA5; the disease is central nervous system cancer.